FDA Inspection
Novo Nordisk A/S - HaxNovo Nordisk A/S - Hax – FDA Inspection, May 1, 2013
Record Details
This FDA Inspection record concerns Novo Nordisk A/S - Hax, with an inspection on May 1, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Novo Nordisk A/S - Hax
- Inspection Date
- May 1, 2013
- Product Type
- Biologics
View Company Profile
ID · 4cde4602-433f-4310-8b73-872a0213f16a
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 834355
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Novo Nordisk A/S - Hax
9| Date | Classification | Office | Project area |
|---|---|---|---|
| June 1, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 8, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 14, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 6, 2015 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 13, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Novo Nordisk A/S - Hax
- FDA Inspection 1238387 - 2023-06-01
- FDA Inspection 1056878 - 2018-05-08
- FDA Inspection 985214 - 2016-06-14
- FDA Inspection 950758 - 2015-11-06
- FDA Inspection 883249 - 2014-05-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.